Trial Profile
Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Ferric pyrophosphate (Primary)
- Indications Iron deficiency anaemia
- Focus Pharmacokinetics
- Sponsors Rockwell Medical Technologies
- 10 Aug 2016 Status changed from not yet recruiting to completed.
- 18 Apr 2016 New trial record